Thus, a very important step has been the discovery of EPI-X4, which as a natural CXCR4 antagonist effectively blocks CXCL12-mediated receptor internalization and suppresses the migration and invasion of cancer cells towards a CXCL12 gradient. This evidence concerns the gene CXCR4 and cancer.